Mark Kunitomi

Mark Kunitomi is the Chief Scientific Officer and Co-Founder at Almaden Genomics. Mark has experience in leading and managing teams, developing scientific roadmaps, and product strategies. Prior to their current role, Mark held research and postdoctoral positions at IBM and UCSF. Mark holds a PhD in Biochemistry and Molecular Biology from the University of California, San Francisco.